Kopran Limited
₹131.83-1.18%Feb 27, 3:45 PM IST
KOPRAN•Health Technology•Pharmaceuticals: Major
Current Price
₹131.83-1.18%
Feb 27, 3:45 PM ISTMarket Cap₹642.92 Cr
Market Cap₹642.92 Cr
Business Overview
Kopran Limited operates through 2 main business divisions including Formulations, Active Pharmaceutical Ingredients (APIs).
Business Hierarchy Structure for Kopran Limited
- Kopran Limited
- Formulations
- Penicillin-based finished oral dosage forms
- Amoxycillin
- Ampicillin
- Cloxacillin
- Amoxy Clauv
- Flucloxacillin
- Phenoxy methyl penicillin
- Non-penicillin-based finished oral dosage forms
- Macrolides
- Cardiovascular
- Anti-helmentics
- Anti-histamine
- CNS
- Anti-diabetic
- Pain Management
- Gastroenterology
- Respiratory
- Penicillin-based finished oral dosage forms
- Active Pharmaceutical Ingredients (APIs)
- API Manufacturing (Kopran Research Laboratories Ltd.)
- Sterile Cephalosporins
- Carbapenems
- Atenolol
- Macrolides
- Granules
- Sterile Carbapenems
- Anti-hypertensive
- Neuromodulator
- Urological
- Anti-infective/Anti-acne
- Anti-thrombotic
- Anti-diabetic
- Intermediates
- API Manufacturing (Kopran Research Laboratories Ltd.)
- Formulations